Milestones in ataxia
Identifieur interne : 001613 ( Main/Merge ); précédent : 001612; suivant : 001614Milestones in ataxia
Auteurs : Thomas Klockgether [Allemagne] ; Henry Paulson [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-05.
English descriptors
- KwdEn :
- Animals, Ataxia (classification), Ataxia (genetics), Ataxia (history), Ataxia (therapy), Biomedical Research (history), Biomedical Research (methods), DNA repair, History, 20th Century, History, 21st Century, Humans, ataxia, clinical scale, ion channel dysfunction, mitochondrial dysfunction, polyglutamine disorders.
- MESH :
- classification : Ataxia.
- genetics : Ataxia.
- history : Ataxia, Biomedical Research.
- methods : Biomedical Research.
- therapy : Ataxia.
- Animals, History, 20th Century, History, 21st Century, Humans.
Abstract
The past 25 years have seen enormous progress in the deciphering of the genetic and molecular basis of ataxias, resulting in improved understanding of their pathogenesis. The most significant milestones during this period were the cloning of the genes associated with the common spinocerebellar ataxias, ataxia telangiectasia, and Friedreich ataxia. To date, the causative mutations of more than 30 spinocerebellar ataxias and 20 recessive ataxias have been identified. In addition, there are numerous acquired ataxias with defined molecular causes, so that the entire number of distinct ataxia disorders exceeds 50 and possibly approaches 100. Despite this enormous heterogeneity, a few recurrent pathophysiological themes stand out. These include protein aggregation, failure of protein homeostasis, perturbations in ion channel function, defects in DNA repair, and mitochondrial dysfunction. The clinical phenotypes of the most common ataxia disorders have been firmly established, and their natural history is being studied in ongoing large observational trials. Effective therapies for ataxias are still lacking. However, novel drug targets are under investigation, and it is expected that there will be an increasing number of therapeutic trials in ataxia. © 2011 Movement Disorder Society
Url:
- https://api.istex.fr/document/2781EBC4611D116E382D330A499271A4F1D1DACF/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105349
DOI: 10.1002/mds.23559
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000801
- to stream Istex, to step Curation: 000801
- to stream Istex, to step Checkpoint: 000292
- to stream Pmc, to step Corpus: 000146
- to stream Pmc, to step Curation: 000146
- to stream Pmc, to step Checkpoint: 000253
- to stream PubMed, to step Corpus: 001165
- to stream PubMed, to step Curation: 001165
- to stream PubMed, to step Checkpoint: 001244
- to stream Ncbi, to step Merge: 003263
- to stream Ncbi, to step Curation: 003263
- to stream Ncbi, to step Checkpoint: 003263
Links to Exploration step
ISTEX:2781EBC4611D116E382D330A499271A4F1D1DACFLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2781EBC4611D116E382D330A499271A4F1D1DACF</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23559</idno><idno type="url">https://api.istex.fr/document/2781EBC4611D116E382D330A499271A4F1D1DACF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000801</idno><idno type="wicri:Area/Istex/Curation">000801</idno><idno type="wicri:Area/Istex/Checkpoint">000292</idno><idno type="wicri:doubleKey">0885-3185:2011:Klockgether T:milestones:in:ataxia</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105349</idno><idno type="RBID">PMC:3105349</idno><idno type="wicri:Area/Pmc/Corpus">000146</idno><idno type="wicri:Area/Pmc/Curation">000146</idno><idno type="wicri:Area/Pmc/Checkpoint">000253</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001165</idno><idno type="wicri:Area/PubMed/Curation">001165</idno><idno type="wicri:Area/PubMed/Checkpoint">001244</idno><idno type="wicri:Area/Ncbi/Merge">003263</idno><idno type="wicri:Area/Ncbi/Curation">003263</idno><idno type="wicri:Area/Ncbi/Checkpoint">003263</idno><idno type="wicri:doubleKey">0885-3185:2011:Klockgether T:milestones:in:ataxia</idno><idno type="wicri:Area/Main/Merge">001613</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Hospital Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Center for Neurodegenerative Disorder (DZNE), Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Michigan, Ann Arbor, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="1134">1134</biblScope><biblScope unit="page" to="1141">1141</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">2781EBC4611D116E382D330A499271A4F1D1DACF</idno><idno type="DOI">10.1002/mds.23559</idno><idno type="ArticleID">MDS23559</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Ataxia (classification)</term><term>Ataxia (genetics)</term><term>Ataxia (history)</term><term>Ataxia (therapy)</term><term>Biomedical Research (history)</term><term>Biomedical Research (methods)</term><term>DNA repair</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term><term>ataxia</term><term>clinical scale</term><term>ion channel dysfunction</term><term>mitochondrial dysfunction</term><term>polyglutamine disorders</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Ataxia</term><term>Biomedical Research</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Biomedical Research</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The past 25 years have seen enormous progress in the deciphering of the genetic and molecular basis of ataxias, resulting in improved understanding of their pathogenesis. The most significant milestones during this period were the cloning of the genes associated with the common spinocerebellar ataxias, ataxia telangiectasia, and Friedreich ataxia. To date, the causative mutations of more than 30 spinocerebellar ataxias and 20 recessive ataxias have been identified. In addition, there are numerous acquired ataxias with defined molecular causes, so that the entire number of distinct ataxia disorders exceeds 50 and possibly approaches 100. Despite this enormous heterogeneity, a few recurrent pathophysiological themes stand out. These include protein aggregation, failure of protein homeostasis, perturbations in ion channel function, defects in DNA repair, and mitochondrial dysfunction. The clinical phenotypes of the most common ataxia disorders have been firmly established, and their natural history is being studied in ongoing large observational trials. Effective therapies for ataxias are still lacking. However, novel drug targets are under investigation, and it is expected that there will be an increasing number of therapeutic trials in ataxia. © 2011 Movement Disorder Society</div></front></TEI><double doi="10.1002/mds.23559"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2781EBC4611D116E382D330A499271A4F1D1DACF</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23559</idno><idno type="url">https://api.istex.fr/document/2781EBC4611D116E382D330A499271A4F1D1DACF/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000801</idno><idno type="wicri:Area/Istex/Curation">000801</idno><idno type="wicri:Area/Istex/Checkpoint">000292</idno><idno type="wicri:doubleKey">0885-3185:2011:Klockgether T:milestones:in:ataxia</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Hospital Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Center for Neurodegenerative Disorder (DZNE), Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Michigan, Ann Arbor, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-05">2011-05</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="1134">1134</biblScope><biblScope unit="page" to="1141">1141</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">2781EBC4611D116E382D330A499271A4F1D1DACF</idno><idno type="DOI">10.1002/mds.23559</idno><idno type="ArticleID">MDS23559</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DNA repair</term><term>ataxia</term><term>clinical scale</term><term>ion channel dysfunction</term><term>mitochondrial dysfunction</term><term>polyglutamine disorders</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The past 25 years have seen enormous progress in the deciphering of the genetic and molecular basis of ataxias, resulting in improved understanding of their pathogenesis. The most significant milestones during this period were the cloning of the genes associated with the common spinocerebellar ataxias, ataxia telangiectasia, and Friedreich ataxia. To date, the causative mutations of more than 30 spinocerebellar ataxias and 20 recessive ataxias have been identified. In addition, there are numerous acquired ataxias with defined molecular causes, so that the entire number of distinct ataxia disorders exceeds 50 and possibly approaches 100. Despite this enormous heterogeneity, a few recurrent pathophysiological themes stand out. These include protein aggregation, failure of protein homeostasis, perturbations in ion channel function, defects in DNA repair, and mitochondrial dysfunction. The clinical phenotypes of the most common ataxia disorders have been firmly established, and their natural history is being studied in ongoing large observational trials. Effective therapies for ataxias are still lacking. However, novel drug targets are under investigation, and it is expected that there will be an increasing number of therapeutic trials in ataxia. © 2011 Movement Disorder Society</div></front></TEI></ISTEX><PMC><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Neurology, University Hospital Bonn, Bonn, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Hospital Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:aff id="A2">German Center for Neurodegenerative Disorder (DZNE), Bonn, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Center for Neurodegenerative Disorder (DZNE), Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Michigan, Ann Arbor, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21626557</idno><idno type="pmc">3105349</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105349</idno><idno type="RBID">PMC:3105349</idno><idno type="doi">10.1002/mds.23559</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">000146</idno><idno type="wicri:Area/Pmc/Curation">000146</idno><idno type="wicri:Area/Pmc/Checkpoint">000253</idno><idno type="wicri:source">PubMed</idno><idno type="wicri:Area/PubMed/Corpus">001165</idno><idno type="wicri:Area/PubMed/Curation">001165</idno><idno type="wicri:Area/PubMed/Checkpoint">001244</idno><idno type="wicri:Area/Ncbi/Merge">003263</idno><idno type="wicri:Area/Ncbi/Curation">003263</idno><idno type="wicri:Area/Ncbi/Checkpoint">003263</idno><idno type="wicri:doubleKey">0885-3185:2011:Klockgether T:milestones:in:ataxia</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Milestones in ataxia</title><author><name sortKey="Klockgether, Thomas" sort="Klockgether, Thomas" uniqKey="Klockgether T" first="Thomas" last="Klockgether">Thomas Klockgether</name><affiliation wicri:level="3"><nlm:aff id="A1">Department of Neurology, University Hospital Bonn, Bonn, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, University Hospital Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:aff id="A2">German Center for Neurodegenerative Disorder (DZNE), Bonn, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>German Center for Neurodegenerative Disorder (DZNE), Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Paulson, Henry" sort="Paulson, Henry" uniqKey="Paulson H" first="Henry" last="Paulson">Henry Paulson</name><affiliation wicri:level="2"><nlm:aff id="A3">Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA</nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Michigan, Ann Arbor, Michigan</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Ataxia (classification)</term><term>Ataxia (genetics)</term><term>Ataxia (history)</term><term>Ataxia (therapy)</term><term>Biomedical Research (history)</term><term>Biomedical Research (methods)</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" qualifier="history" xml:lang="en"><term>Ataxia</term><term>Biomedical Research</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Biomedical Research</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Ataxia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>History, 20th Century</term><term>History, 21st Century</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P5">The past 25 years have seen enormous progress in the deciphering of the genetic and molecular basis of ataxias resulting in an improved understanding of their pathogenesis. The most significant milestones during this period were the cloning of the genes associated with the common spinocerebellar ataxias (SCAs), ataxia telangiectasia (AT) and Friedreich ataxia (FRDA). To date, the causative mutations of more than 30 SCAs and 20 recessive ataxias have been identified. In addition, there are numerous acquired ataxias with defined molecular causes so that the entire number of distinct ataxia disorders exceeds 50 and possibly approaches 100. Despite this enormous heterogeneity, a few recurrent pathopyhsiological themes stand out. These include protein aggregation, failure of protein homoestasis, perturbations in ion channel function, defects in DNA repair and mitochondrial dysfunction. The clinical phenotypes of the most common ataxia disorders have been firmly established, and their natural history is being studied in ongoing large observational trials. Effective therapies for ataxias are still lacking. However, novel drug targets are under investigation, and it is expected that there will be an increasing number of therapeutic trials in ataxia.</p></div></front></TEI></PMC></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001613 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001613 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:2781EBC4611D116E382D330A499271A4F1D1DACF
|texte= Milestones in ataxia
}}
| This area was generated with Dilib version V0.6.23. |  |